Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia

Arichika Hoshino, Cindy J. Yee, Mel Campbell, Randall (Randy) Woltjer, Rebecca L. Townsend, Riet Van Der Meer, Yu Shyr, Jeffrey T. Holt, Harold L. Moses, Roy A. Jensen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to express the human transgene in their mammary glands. The mammary glands of 13-week-old virgin homozygous MMTV-BRCA1 mice presented the morphology of moderately increased lobulo-alveolar development. The mammary ductal trees of both hemizygous and homozygous MMTV-BRCA1t340 were similar to those of control non-transgenic littermates. Interestingly, both hemi- and homozygous mice expressing a splice variant of BRCA1 lacking the N-terminal RING finger domain (MMTV-BRCA1sv) exhibited marked mammary lobulo-alveolar development, particularly terminal end bud proliferation. Morphometric analyses of mammary gland whole mount preparations were used to measure epithelial staining indices of ∼35% for homozygous MMTV-BRCA1 mice and ∼60% for both hemizygous and homozygous MMTV-BRCA1sv mice versus ∼25% for non-transgenic mice. Homozygous MMTV-BRCA1 mice showed delayed development of tumors when challenged with 7,12 dimethylbenzanthracene (DMBA), relative to non-transgenic and homozygous BRCA1t340 expressing mice. In contrast, homozygous MMTV-BRCA1sv transgenic animals were sensitized to DMBA treatment and exhibited a very rapid onset of mammary tumor development and accelerated mortality. MMTV-BRCA1 effects on mortality were restricted to DMBA-induced tumors of the mammary gland. These results demonstrate in vivo roles for BRCA1 in both mammary gland development and in tumor suppression against mutagen-induced mammary gland neoplasia.

Original languageEnglish (US)
Pages (from-to)281-291
Number of pages11
JournalInternational Journal of Biological Sciences
Volume3
Issue number5
StatePublished - Apr 25 2007
Externally publishedYes

Fingerprint

Mouse mammary tumor virus
Mutagens
Human Mammary Glands
Transgenes
tumor
mammary glands
transgenes
breasts
Breast
neoplasms
mice
virus
Neoplasms
transgenic animals
Genetically Modified Animals
mammary neoplasms (animal)
Transgenic Mice
adolescence
RING Finger Domains
genetically modified organisms

Keywords

  • BRCA1 gene
  • Mammary gland development
  • Transgenic mice

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Molecular Biology
  • Ecology, Evolution, Behavior and Systematics
  • Applied Microbiology and Biotechnology

Cite this

Hoshino, A., Yee, C. J., Campbell, M., Woltjer, R. R., Townsend, R. L., Van Der Meer, R., ... Jensen, R. A. (2007). Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. International Journal of Biological Sciences, 3(5), 281-291.

Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. / Hoshino, Arichika; Yee, Cindy J.; Campbell, Mel; Woltjer, Randall (Randy); Townsend, Rebecca L.; Van Der Meer, Riet; Shyr, Yu; Holt, Jeffrey T.; Moses, Harold L.; Jensen, Roy A.

In: International Journal of Biological Sciences, Vol. 3, No. 5, 25.04.2007, p. 281-291.

Research output: Contribution to journalArticle

Hoshino, A, Yee, CJ, Campbell, M, Woltjer, RR, Townsend, RL, Van Der Meer, R, Shyr, Y, Holt, JT, Moses, HL & Jensen, RA 2007, 'Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia', International Journal of Biological Sciences, vol. 3, no. 5, pp. 281-291.
Hoshino, Arichika ; Yee, Cindy J. ; Campbell, Mel ; Woltjer, Randall (Randy) ; Townsend, Rebecca L. ; Van Der Meer, Riet ; Shyr, Yu ; Holt, Jeffrey T. ; Moses, Harold L. ; Jensen, Roy A. / Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia. In: International Journal of Biological Sciences. 2007 ; Vol. 3, No. 5. pp. 281-291.
@article{2647511498764a04ac3a2bc9f415d081,
title = "Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia",
abstract = "To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to express the human transgene in their mammary glands. The mammary glands of 13-week-old virgin homozygous MMTV-BRCA1 mice presented the morphology of moderately increased lobulo-alveolar development. The mammary ductal trees of both hemizygous and homozygous MMTV-BRCA1t340 were similar to those of control non-transgenic littermates. Interestingly, both hemi- and homozygous mice expressing a splice variant of BRCA1 lacking the N-terminal RING finger domain (MMTV-BRCA1sv) exhibited marked mammary lobulo-alveolar development, particularly terminal end bud proliferation. Morphometric analyses of mammary gland whole mount preparations were used to measure epithelial staining indices of ∼35{\%} for homozygous MMTV-BRCA1 mice and ∼60{\%} for both hemizygous and homozygous MMTV-BRCA1sv mice versus ∼25{\%} for non-transgenic mice. Homozygous MMTV-BRCA1 mice showed delayed development of tumors when challenged with 7,12 dimethylbenzanthracene (DMBA), relative to non-transgenic and homozygous BRCA1t340 expressing mice. In contrast, homozygous MMTV-BRCA1sv transgenic animals were sensitized to DMBA treatment and exhibited a very rapid onset of mammary tumor development and accelerated mortality. MMTV-BRCA1 effects on mortality were restricted to DMBA-induced tumors of the mammary gland. These results demonstrate in vivo roles for BRCA1 in both mammary gland development and in tumor suppression against mutagen-induced mammary gland neoplasia.",
keywords = "BRCA1 gene, Mammary gland development, Transgenic mice",
author = "Arichika Hoshino and Yee, {Cindy J.} and Mel Campbell and Woltjer, {Randall (Randy)} and Townsend, {Rebecca L.} and {Van Der Meer}, Riet and Yu Shyr and Holt, {Jeffrey T.} and Moses, {Harold L.} and Jensen, {Roy A.}",
year = "2007",
month = "4",
day = "25",
language = "English (US)",
volume = "3",
pages = "281--291",
journal = "International Journal of Biological Sciences",
issn = "1449-2288",
publisher = "Ivyspring International Publisher",
number = "5",

}

TY - JOUR

T1 - Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia

AU - Hoshino, Arichika

AU - Yee, Cindy J.

AU - Campbell, Mel

AU - Woltjer, Randall (Randy)

AU - Townsend, Rebecca L.

AU - Van Der Meer, Riet

AU - Shyr, Yu

AU - Holt, Jeffrey T.

AU - Moses, Harold L.

AU - Jensen, Roy A.

PY - 2007/4/25

Y1 - 2007/4/25

N2 - To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to express the human transgene in their mammary glands. The mammary glands of 13-week-old virgin homozygous MMTV-BRCA1 mice presented the morphology of moderately increased lobulo-alveolar development. The mammary ductal trees of both hemizygous and homozygous MMTV-BRCA1t340 were similar to those of control non-transgenic littermates. Interestingly, both hemi- and homozygous mice expressing a splice variant of BRCA1 lacking the N-terminal RING finger domain (MMTV-BRCA1sv) exhibited marked mammary lobulo-alveolar development, particularly terminal end bud proliferation. Morphometric analyses of mammary gland whole mount preparations were used to measure epithelial staining indices of ∼35% for homozygous MMTV-BRCA1 mice and ∼60% for both hemizygous and homozygous MMTV-BRCA1sv mice versus ∼25% for non-transgenic mice. Homozygous MMTV-BRCA1 mice showed delayed development of tumors when challenged with 7,12 dimethylbenzanthracene (DMBA), relative to non-transgenic and homozygous BRCA1t340 expressing mice. In contrast, homozygous MMTV-BRCA1sv transgenic animals were sensitized to DMBA treatment and exhibited a very rapid onset of mammary tumor development and accelerated mortality. MMTV-BRCA1 effects on mortality were restricted to DMBA-induced tumors of the mammary gland. These results demonstrate in vivo roles for BRCA1 in both mammary gland development and in tumor suppression against mutagen-induced mammary gland neoplasia.

AB - To characterize the role of BRCA1 in mammary gland development and tumor suppression, a transgenic mouse model of BRCA1 overexpression was developed. Using the mouse mammary tumor virus (MMTV) promoter/enhancer, transgenic mice expressing human BRCA1 or select mutant controls were generated. Transgenic animals examined during adolescence were shown to express the human transgene in their mammary glands. The mammary glands of 13-week-old virgin homozygous MMTV-BRCA1 mice presented the morphology of moderately increased lobulo-alveolar development. The mammary ductal trees of both hemizygous and homozygous MMTV-BRCA1t340 were similar to those of control non-transgenic littermates. Interestingly, both hemi- and homozygous mice expressing a splice variant of BRCA1 lacking the N-terminal RING finger domain (MMTV-BRCA1sv) exhibited marked mammary lobulo-alveolar development, particularly terminal end bud proliferation. Morphometric analyses of mammary gland whole mount preparations were used to measure epithelial staining indices of ∼35% for homozygous MMTV-BRCA1 mice and ∼60% for both hemizygous and homozygous MMTV-BRCA1sv mice versus ∼25% for non-transgenic mice. Homozygous MMTV-BRCA1 mice showed delayed development of tumors when challenged with 7,12 dimethylbenzanthracene (DMBA), relative to non-transgenic and homozygous BRCA1t340 expressing mice. In contrast, homozygous MMTV-BRCA1sv transgenic animals were sensitized to DMBA treatment and exhibited a very rapid onset of mammary tumor development and accelerated mortality. MMTV-BRCA1 effects on mortality were restricted to DMBA-induced tumors of the mammary gland. These results demonstrate in vivo roles for BRCA1 in both mammary gland development and in tumor suppression against mutagen-induced mammary gland neoplasia.

KW - BRCA1 gene

KW - Mammary gland development

KW - Transgenic mice

UR - http://www.scopus.com/inward/record.url?scp=34248175282&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248175282&partnerID=8YFLogxK

M3 - Article

C2 - 17505536

AN - SCOPUS:34248175282

VL - 3

SP - 281

EP - 291

JO - International Journal of Biological Sciences

JF - International Journal of Biological Sciences

SN - 1449-2288

IS - 5

ER -